These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6739373)
61. [Hormone therapy of male genital cancer (prostatic cancer)]. Machida T; Ikemoto I Gan To Kagaku Ryoho; 1987 Oct; 14(10):2845-52. PubMed ID: 2444164 [TBL] [Abstract][Full Text] [Related]
68. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate. Fosså SD; Fosså J; Aakvaag A J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240 [TBL] [Abstract][Full Text] [Related]
69. Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: a randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate. The Dutch Estracyt Study Group. Janknegt RA; Boon TA; van de Beek C; Grob P Urology; 1997 Mar; 49(3):411-20. PubMed ID: 9123707 [TBL] [Abstract][Full Text] [Related]
70. Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900. Schmidt JD Prostate; 1984; 5(4):387-99. PubMed ID: 6377283 [TBL] [Abstract][Full Text] [Related]
71. DNA content in cells aspirated from carcinoma of the prostate treated with oestrogenic compounds. Kjaer TB; Thommesen P; Frederiksen P; Bichel P Urol Res; 1979 Dec; 7(4):249-51. PubMed ID: 524561 [No Abstract] [Full Text] [Related]
73. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer. Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866 [TBL] [Abstract][Full Text] [Related]
74. A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. Murphy GP; Gibbons RP; Johnson DE; Loening SA; Prout GR; Schmidt JD; Bross DS; Chu TM; Gaeta JF; Saroff J; Scott WW J Urol; 1977 Aug; 118(2):288-91. PubMed ID: 142845 [No Abstract] [Full Text] [Related]
75. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer. Benson RC; Cummings K Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984 [No Abstract] [Full Text] [Related]
76. The EORTC Phase III trials in prostatic cancer. Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132 [No Abstract] [Full Text] [Related]
77. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study. Flüchter SH; Nelde HJ; Björk P; Müntzing J; Bichler KH Prostate; 1989; 14(1):27-43. PubMed ID: 2648345 [TBL] [Abstract][Full Text] [Related]
78. Oral estramustine phosphate (Estracyt): a broad phase II study. Halpern J; Catane R J Med; 1984; 15(1):35-43. PubMed ID: 6593404 [TBL] [Abstract][Full Text] [Related]